A triple advantage can be achieved by shifting Mexicans' current diet toward that of the recommended Healthy and Sustainable ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

PFAS are causing significant harm to the environment, people, pets, and wildlife, but it's not clear that proposed solutions ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...